Literature DB >> 12645685

Concealed medicines for people with schizophrenia: a U.S. perspective.

Scott Stroup1, Marvin Swartz, Paul Appelbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12645685     DOI： 10.1093/oxfordjournals.schbul.a006961

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  6 in total

Review 1.  Dysphagia is a common and serious problem for adults with mental illness: a systematic review.

Authors:  Kristy J Aldridge; Nicholas F Taylor
Journal:  Dysphagia       Date:  2011-11-26       Impact factor: 3.438

2.  Families and medication use and adherence among Latinos with schizophrenia.

Authors:  Mercedes Hernandez; Concepción Barrio
Journal:  J Ment Health       Date:  2016-10-01

3.  The noncompliant patient in psychiatry: the case for and against covert/surreptitious medication.

Authors:  K S Latha
Journal:  Mens Sana Monogr       Date:  2010-01

4.  Covert medication: Do means justify the ends?

Authors:  T S Sathyanarayana Rao; Roy Abraham Kallilvayalil; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

5.  Surreptitious practices in the management of persons with serious mental illnesses - Perspectives from the schizophrenia research foundation.

Authors:  Padmavati Ramachandran; Thara Rangaswamy
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

6.  Covert medication and patient identity: placing the ethical analysis in a worldwide context.

Authors:  Neil John Pickering
Journal:  J Med Ethics       Date:  2020-12-17       Impact factor: 2.903
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.